REGENXBIO Gestione
Gestione criteri di controllo 2/4
REGENXBIO Il CEO è Curran Simpson, nominato in Jul2024, e ha un mandato di meno di un anno. la retribuzione annua totale è $ 2.95M, composta da 17.4% di stipendio e 82.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.031% delle azioni della società, per un valore di $ 147.91K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.9 anni e 7.4 anni.
Informazioni chiave
Curran Simpson
Amministratore delegato
US$3.0m
Compenso totale
| Percentuale dello stipendio del CEO | 17.4% |
| Mandato del CEO | less than a year |
| Proprietà del CEO | 0.03% |
| Durata media del management | 5.9yrs |
| Durata media del Consiglio di amministrazione | 7.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
REGENXBIO: With Additional MPS II Data, Program Advancement Remains On Track
Oct 31Does REGENXBIO (NASDAQ:RGNX) Have A Healthy Balance Sheet?
Sep 12
Regenxbio: RGX-121 Could Achieve A First For Rare Neurodegenerative Disorder
Aug 06REGENXBIO Inc. (NASDAQ:RGNX) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 04Revenues Working Against REGENXBIO Inc.'s (NASDAQ:RGNX) Share Price
Jul 26Regenxbio: Transforming Gene Therapy With Innovative AAV Treatments, Strong Buy
Jun 11REGENXBIO Inc. (NASDAQ:RGNX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
May 11REGENXBIO Inc. (NASDAQ:RGNX) Not Doing Enough For Some Investors As Its Shares Slump 26%
Apr 25Regenxbio: DMD Program Lends Additional Credibility To NAV Technology Platform
Mar 11Analysts Just Slashed Their REGENXBIO Inc. (NASDAQ:RGNX) EPS Numbers
Mar 07Improved Revenues Required Before REGENXBIO Inc. (NASDAQ:RGNX) Stock's 75% Jump Looks Justified
Mar 05Earnings Update: REGENXBIO Inc. (NASDAQ:RGNX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Mar 02Regenxbio: Robust Data, Decent Cash, Never Ending Trials, Buying At Dips
Jan 19There's No Escaping REGENXBIO Inc.'s (NASDAQ:RGNX) Muted Revenues
Dec 21We Think REGENXBIO (NASDAQ:RGNX) Needs To Drive Business Growth Carefully
Nov 09Will REGENXBIO (NASDAQ:RGNX) Spend Its Cash Wisely?
Aug 08REGENXBIO Inc. (NASDAQ:RGNX) Analysts Just Trimmed Their Revenue Forecasts By 12%
May 11Here's Why We're Watching REGENXBIO's (NASDAQ:RGNX) Cash Burn Situation
May 08Analysts Are More Bearish On REGENXBIO Inc. (NASDAQ:RGNX) Than They Used To Be
Mar 05Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$239m |
| Jun 30 2024 | n/a | n/a | -US$241m |
| Mar 31 2024 | n/a | n/a | -US$260m |
| Dec 31 2023 | US$3m | US$513k | -US$263m |
| Sep 30 2023 | n/a | n/a | -US$261m |
| Jun 30 2023 | n/a | n/a | -US$274m |
| Mar 31 2023 | n/a | n/a | -US$270m |
| Dec 31 2022 | US$2m | US$475k | -US$280m |
| Sep 30 2022 | n/a | n/a | US$74m |
| Jun 30 2022 | n/a | n/a | US$91m |
| Mar 31 2022 | n/a | n/a | US$101m |
| Dec 31 2021 | US$3m | US$448k | US$128m |
| Sep 30 2021 | n/a | n/a | -US$212m |
| Jun 30 2021 | n/a | n/a | -US$145m |
| Mar 31 2021 | n/a | n/a | -US$121m |
| Dec 31 2020 | US$2m | US$428k | -US$111m |
| Sep 30 2020 | n/a | n/a | -US$91m |
| Jun 30 2020 | n/a | n/a | -US$135m |
| Mar 31 2020 | n/a | n/a | -US$103m |
| Dec 31 2019 | US$2m | US$382k | -US$95m |
| Sep 30 2019 | n/a | n/a | -US$64m |
| Jun 30 2019 | n/a | n/a | -US$49m |
| Mar 31 2019 | n/a | n/a | -US$37m |
| Dec 31 2018 | US$2m | US$371k | US$100m |
| Sep 30 2018 | n/a | n/a | US$80m |
| Jun 30 2018 | n/a | n/a | US$78m |
| Mar 31 2018 | n/a | n/a | US$53m |
| Dec 31 2017 | US$912k | US$361k | -US$73m |
Compensazione vs Mercato: La retribuzione totale di Curran ($USD 2.95M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 2.24M ).
Compensazione vs guadagni: La retribuzione di Curran è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Curran Simpson (62 yo)
less than a year
Mandato
US$2,950,002
Compensazione
Mr. Curran M. Simpson, M.S., had been the Chief Operating Officer at REGENXBIO Inc. since January 2023 until July 01, 2024 and served as its Executive Vice President until July 01, 2024 and serves as its P...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | less than a year | US$2.95m | 0.031% $ 147.9k | |
| Executive VP & Chief Scientific Officer | 7.7yrs | US$2.99m | 0.061% $ 289.4k | |
| Advisor | less than a year | US$2.62m | 0.38% $ 1.8m | |
| Executive VP & Chief Medical Officer | 5.6yrs | US$3.31m | 0% $ 0 | |
| Executive VP & CFO | less than a year | Nessun dato | Nessun dato | |
| Executive VP & Chief Legal Officer | 8.3yrs | US$3.44m | 0.046% $ 219.5k | |
| Chief Communications & People Officer | 7.1yrs | Nessun dato | Nessun dato | |
| Executive VP of Commercial Strategy & Operations | 6.3yrs | Nessun dato | Nessun dato |
5.9yrs
Durata media
55yo
Età media
Gestione esperta: Il team dirigenziale di RGNX è esperto e expertise (durata media dell'incarico 5.9 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | less than a year | US$2.95m | 0.031% $ 147.9k | |
| Independent Director | 9.1yrs | US$339.98k | 0.0061% $ 29.0k | |
| Independent Director | 3.2yrs | US$339.98k | 0.0061% $ 29.0k | |
| Independent Director | 9.5yrs | US$352.48k | 0.013% $ 62.6k | |
| Member of Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Director | 15.8yrs | US$354.98k | 6.39% $ 30.5m | |
| Member of Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Independent Director | 6.5yrs | US$327.48k | 0.0061% $ 29.0k | |
| Lead Independent Director | 8.3yrs | US$334.98k | 0.0061% $ 29.0k | |
| Independent Director | 3.2yrs | US$324.98k | 0.0061% $ 29.0k | |
| Chairman | 15.7yrs | US$5.92m | 0.63% $ 3.0m | |
| Independent Director | 2.4yrs | US$329.98k | 0.0040% $ 19.3k |
7.4yrs
Durata media
69.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di RGNX sono considerati esperti (durata media dell'incarico 7.4 anni).